An integrated analysis of C5AR2 related to malignant properties and immune infiltration of gliomas

Abstract Background C5AR2 is recognized as a proinflammatory molecule and activates the inflammatory response in multiple disorders. However, little has been reported on C5AR2 in glioma. This study sought to explore its expression, biological function, and association with clinical pathological indi...

Full description

Bibliographic Details
Published in:	Cancer Innovation
Main Authors:	Chengying Huang, Ouwen Qiu, Chaofu Mao, Zhicheng Hu, Shanqiang Qu
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Subjects:	biomarker glioma immunotherapy microenvironment prognosis
Online Access:	https://doi.org/10.1002/cai2.29

Similar Items

Prognostic values and immune infiltration of KLF15, AQP7, AGPAT9 in glioma and glioblastoma
by: Ayobami Matthew Olajuyin, et al.
Published: (2024-03-01)

Roles of Tenascin-XB in the Glioma Immune Microenvironment
by: Chaofu Ma, et al.
Published: (2023-05-01)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
by: Shenghua Zhuo, et al.
Published: (2023-12-01)

Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
by: Chaofu Mao, et al.
Published: (2022-12-01)

The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide
by: Shanqiang Qu, et al.
Published: (2025-07-01)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
by: Sibin Zhang, et al.
Published: (2022-06-01)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
by: Haiyan Yang, et al.
Published: (2022-10-01)

A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
by: Huaide Qiu, et al.
Published: (2020-12-01)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
by: Feng Wang, et al.
Published: (2022-07-01)

PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis
by: Kaiming Ma, et al.
Published: (2022-08-01)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
by: Peng Li, et al.
Published: (2022-06-01)

Expression of overall survival-EMT-immune cell infiltration genes predict the prognosis of glioma
by: Lei Zheng, et al.
Published: (2024-06-01)

Prognostic Value of MEG3 and Its Correlation With Immune Infiltrates in Gliomas
by: Xiaoping Xu, et al.
Published: (2021-06-01)

EFNB1 drives glioma progression and shapes the immune microenvironment: a potential prognostic biomarker
by: Yungui Zheng, et al.
Published: (2025-02-01)

Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas
by: Xin Tang, et al.
Published: (2022-11-01)

SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
by: Houshi Xu, et al.
Published: (2022-11-01)

A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
by: Yanbo Yang, et al.
Published: (2024-01-01)

ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas
by: Yue Ming, et al.
Published: (2023-10-01)

SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insights
by: Ren Geng, et al.
Published: (2024-04-01)

Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma
by: Peng Lv, et al.
Published: (2025-02-01)

Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin
by: Laiba Noor, et al.
Published: (2024-10-01)

Emerging hallmark of gliomas microenvironment in evading immunity: a basic concept
by: Muhammad Reza Arifianto, et al.
Published: (2023-03-01)

TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis
by: Bingcheng Wang, et al.
Published: (2024-01-01)

Machine learning-based identification of histone deacetylase-associated prognostic factors and prognostic modeling for low-grade glioma
by: Keshan Wen, et al.
Published: (2024-12-01)

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma
by: Ying Qi, et al.
Published: (2022-01-01)

Impact of redox-related genes on tumor microenvironment immune characteristics and prognosis of high-grade gliomas
by: Yunbo Yuan, et al.
Published: (2023-05-01)

Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
by: Junsheng Li, et al.
Published: (2022-04-01)

MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis
by: Yuanhao Lv, et al.
Published: (2025-02-01)

Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma
by: Dongcheng Xie, et al.
Published: (2024-03-01)

Editorial: Insights and implications of mechanisms shaping glioma immune landscape, immunotherapy resistance, and relevant translational research
by: Xiangqi Meng, et al.
Published: (2024-09-01)

Integrated analysis based on vesicle trafficking‐related genes identifying CNIH4 as a novel therapeutic target for glioma
by: Zhen Fang, et al.
Published: (2023-06-01)

Expression profile and prognostic relevance of immune infiltration-related RBMS1 in gliomas: a multidimensional integrative analysis
by: Yang Zhang, et al.
Published: (2025-07-01)

The role of costimulatory molecules in glioma biology and immune microenvironment
by: Ji Wang, et al.
Published: (2022-11-01)

MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma
by: Di Chen, et al.
Published: (2024-01-01)

Liquid biopsy-based identification of prognostic and immunotherapeutically relevant gene signatures in lower grade glioma
by: Changwu Wu, et al.
Published: (2023-02-01)

m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomas
by: Jie Lu, et al.
Published: (2025-02-01)

Comprehensive analysis of bulk, single-cell RNA sequencing, and spatial transcriptomics revealed IER3 for predicting malignant progression and immunotherapy efficacy in glioma
by: Qi Wang, et al.
Published: (2024-10-01)

The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy
by: Xiaoben Wu, et al.
Published: (2022-05-01)

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
by: Soumaya Rafii, et al.
Published: (2023-05-01)

Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas
by: Daqiang Song, et al.
Published: (2024-03-01)